Login

Johan Strid, CEO of Prevas AB, presentation at the 2021 annual meeting focused on strategic initiatives and company performance. 00:10:00

Share On Facebook Share On Twitter

Johan Strid is CEO of the Prevas

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Empowering Independent Agents In Insurtech|Adam Blumencranz,Partner,Distributed Ventures
00:10:00
Company Overview and Strategic Objectives: Interview with Aura Minerals at One-to-One Mining Investment Conference
00:10:00
Diversifying Revenue Streams and Adapting to Consumer Sophistication | Donald C Wood, CEO, Federal Realty Investment Trust.
00:10:00
CAREL Industries Spa's Officer aims to analyze the company's sales strategies, processes, and methodologies.
00:10:00
"INDepth with Victoria Hardie: Exploring High-Conviction, Scalable Real Asset Strategies at HMC Capital"
00:10:00
The 'secret' Creandum tech-exit database|Staffan Helgesson,General Partner,Creandum
00:10:00
Get to Know Tim Schau: Syverson Strege Team | Tim Schau - IT Support Specialist of Syverson Strege
00:10:00
Stablecoins & The Long Case for Bitcoin|Nic Carter,Founding Partner,Castle Island Ventures
00:10:00
SPCG's Multifaceted Solar Energy and Infrastructure Ventures under President | Ms. Wandee Kulcharnyakong Chulcharoen, CEO , Spcg PCL .
00:10:00
Innovating Sustainability: Insights from Berry Global's John Vassallo and Jessica Wojnicki Rodriguez at CPHI Milan | John Vassallo - VP Global R&D, Jessica Wojnicki Rodriguez - Sustainability Project Manager, Berry Global
00:00:00
2020's Servitec Foraco Corporate Video | DANIEL SIMONCINI, CHIEF EXECUTIVE OFFICER, FORACO INTERNATIONAL
00:10:00
How to Break Into Venture Capital (VC)|Lindy Morris Fishburne,Managing Partner,Breakout Ventures

© 2017 - Neuhu+